Developing new regulatory approaches to antimicrobial safety

Journal of Veterinary Medicine Series B: Infectious Diseases and Veterinary Public Health

Volumn 51, Issue 8-9, 2004, Pages 415-418

  Tollefson, L ^a,b  

^a Center for Veterinary Medicine   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VETERINARY DRUG;

ANIMAL; ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PLANNING; HUMAN; MEAT; RISK ASSESSMENT; STANDARD; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HEALTH PLANNING GUIDELINES; HUMANS; MEAT; RISK ASSESSMENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VETERINARY DRUGS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 9244249234     PISSN: 09311793     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0450.2004.00781.x     Document Type: Conference Paper

References (8)

1. van den Bogaard, A. E., and E. E. Stobberingh, 2000: Epidemiology of resistance to antibiotics. Links between animals and humans. Int. J. Antimicrob. Agents 14, 327-335.
2. Cohen, M. L., and R. V. Tauxe, 1986: Drug-resistant Salmonella in the United States: an epidemiologic perspective. Science 234, 964-969.
3. Committee on the Institutional Means for Assessment of Risks to Public Health, Commission on Life Sciences, and National Research Council, 1983: Risk Assessment in the Federal Government: Managing the Process. National Academy Press, Washington, DC.
4. Docic, M., and G. Bilkei, 2003: Differences in antibiotic resistance in Escherichia coli, isolated from East European swine herds with or without prophylactic use of antibiotics. J. Vet. Med. B 50, 27-30.
5. Gupta, A., J. M. Nelson, T. J. Barrett, R. V. Tauxe, S. P. Rossiter, C. R. Friedman, K. W. Joyce, K. E. Smith, T. F. Jones, M. A. Hawkins, B. Shiferaw, J. L. Beebe, D. J. Vugia, T. Rabatsky-Ehr, J. A. Benson, T. P. Root and F. J. Angulo, 2004: Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg. Infect. Dis. Available at: http://www.cdc.gov/ncidod/ EID/vol10no6/03-0635.htm. Accessed June 25, 2004.
6. Mølbak, K., D. L. Baggesen, F. M. Aarestrup, J. M. Ebbesen, J. Engberg, K. Frydendahl, P. Gerner-Smidt, A. M. Petersen, and H. C. Wegener, 1999: An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N. Engl. J. Med. 341, 1420-1425.
7. US Food and Drug Administration, Center for Veterinary Medicine, 2003: Guidance for Industry No. 152: Evaluating the Safety of Antimicrobial new Animal Drugs with regard to their Microbiological Effects on Bacteria of Human Health Concern. Available at: http://www.fda.gov/cvm/guidance/fguide152.pdf Accessed June 25, 2004.
8. Vose, D., J. Acar, F. Anthony, A. Franklin, R. Gupta, T. Nicholls, Y. Tamura, S. Thompson, E. J. Threlfall, M. van Vuuren, and D. G. White, 2001: Antimicrobial resistance: risk analysis methodology for the potential impact on public health of antimicrobial resistant bacteria of animal origin. Rev. Sci. Technol. 20, 811-827 (Office of International Epizootics, Paris).